GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PAX5
|
ENSG00000196092.8 | paired box 5 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PAX5 | hg19_v2_chr9_-_37034028_37034157 | 0.55 | 1.6e-18 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106069247 | 42.50 |
ENST00000479229.1
|
RP11-731F5.1
|
RP11-731F5.1 |
chr9_+_139874683 | 40.04 |
ENST00000444903.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr9_+_139873264 | 31.18 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr9_+_139871948 | 25.79 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
chr22_+_23101182 | 25.21 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr2_+_89986318 | 23.47 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr22_+_23040274 | 22.23 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr17_-_42992856 | 19.41 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
chr16_+_85942594 | 18.69 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr16_+_226658 | 18.36 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
chr22_+_23165153 | 18.31 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr17_+_1674982 | 17.37 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr9_+_74526384 | 17.19 |
ENST00000334731.2
ENST00000377031.3 |
C9orf85
|
chromosome 9 open reading frame 85 |
chr11_-_5248294 | 17.06 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
chr17_-_42580738 | 16.58 |
ENST00000585614.1
ENST00000591680.1 ENST00000434000.1 ENST00000588554.1 ENST00000592154.1 |
GPATCH8
|
G patch domain containing 8 |
chr18_-_74728998 | 16.03 |
ENST00000359645.3
ENST00000397875.3 ENST00000397869.3 ENST00000578193.1 ENST00000578873.1 ENST00000397866.4 ENST00000528160.1 ENST00000527041.1 ENST00000526111.1 ENST00000397865.5 ENST00000382582.3 |
MBP
|
myelin basic protein |
chr4_-_57524061 | 15.90 |
ENST00000508121.1
|
HOPX
|
HOP homeobox |
chr17_-_79105734 | 15.70 |
ENST00000417379.1
|
AATK
|
apoptosis-associated tyrosine kinase |
chrX_+_129473859 | 15.55 |
ENST00000424447.1
|
SLC25A14
|
solute carrier family 25 (mitochondrial carrier, brain), member 14 |
chr2_-_11272234 | 15.50 |
ENST00000590207.1
ENST00000417697.2 ENST00000396164.1 ENST00000536743.1 ENST00000544306.1 |
AC062028.1
|
AC062028.1 |
chr3_-_58572760 | 15.44 |
ENST00000447756.2
|
FAM107A
|
family with sequence similarity 107, member A |
chr1_+_10270863 | 15.36 |
ENST00000377093.4
ENST00000263934.6 |
KIF1B
|
kinesin family member 1B |
chr19_+_47852538 | 15.17 |
ENST00000328771.4
|
DHX34
|
DEAH (Asp-Glu-Ala-His) box polypeptide 34 |
chr20_+_46130671 | 15.16 |
ENST00000371998.3
ENST00000371997.3 |
NCOA3
|
nuclear receptor coactivator 3 |
chr6_-_84419101 | 15.06 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr3_-_58613323 | 15.06 |
ENST00000474531.1
ENST00000465970.1 |
FAM107A
|
family with sequence similarity 107, member A |
chr5_-_139944196 | 15.05 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr19_+_18208603 | 14.91 |
ENST00000262811.6
|
MAST3
|
microtubule associated serine/threonine kinase 3 |
chr2_+_89901292 | 14.86 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr10_+_76871353 | 14.43 |
ENST00000542569.1
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr12_+_53773944 | 14.35 |
ENST00000551969.1
ENST00000327443.4 |
SP1
|
Sp1 transcription factor |
chr6_-_46459675 | 14.24 |
ENST00000306764.7
|
RCAN2
|
regulator of calcineurin 2 |
chr20_+_49575342 | 14.16 |
ENST00000244051.1
|
MOCS3
|
molybdenum cofactor synthesis 3 |
chr9_+_33290491 | 14.15 |
ENST00000379540.3
ENST00000379521.4 ENST00000318524.6 |
NFX1
|
nuclear transcription factor, X-box binding 1 |
chr7_-_129845313 | 14.12 |
ENST00000397622.2
|
TMEM209
|
transmembrane protein 209 |
chr12_-_91539918 | 14.10 |
ENST00000548218.1
|
DCN
|
decorin |
chr7_+_77325738 | 14.03 |
ENST00000334955.8
|
RSBN1L
|
round spermatid basic protein 1-like |
chr14_-_77843390 | 13.49 |
ENST00000216468.7
|
TMED8
|
transmembrane emp24 protein transport domain containing 8 |
chr22_-_37882395 | 13.36 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr7_-_129845188 | 13.25 |
ENST00000462753.1
ENST00000471077.1 ENST00000473456.1 ENST00000336804.8 |
TMEM209
|
transmembrane protein 209 |
chr1_-_160001737 | 13.18 |
ENST00000368090.2
|
PIGM
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr1_+_46668994 | 13.09 |
ENST00000371980.3
|
LURAP1
|
leucine rich adaptor protein 1 |
chr19_-_18314836 | 13.03 |
ENST00000464076.3
ENST00000222256.4 |
RAB3A
|
RAB3A, member RAS oncogene family |
chr12_-_53601000 | 13.03 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
chr19_+_41284121 | 13.00 |
ENST00000594800.1
ENST00000357052.2 ENST00000602173.1 |
RAB4B
|
RAB4B, member RAS oncogene family |
chr3_+_14989186 | 12.91 |
ENST00000435454.1
ENST00000323373.6 |
NR2C2
|
nuclear receptor subfamily 2, group C, member 2 |
chr5_-_139943830 | 12.71 |
ENST00000412920.3
ENST00000511201.2 ENST00000356738.2 ENST00000354402.5 ENST00000358580.5 ENST00000508496.2 |
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
chr14_-_106174960 | 12.69 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr19_-_48018203 | 12.68 |
ENST00000595227.1
ENST00000593761.1 ENST00000263354.3 |
NAPA
|
N-ethylmaleimide-sensitive factor attachment protein, alpha |
chr6_-_32634425 | 12.67 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr17_+_74733744 | 12.65 |
ENST00000586689.1
ENST00000587661.1 ENST00000593181.1 ENST00000336509.4 ENST00000355954.3 |
MFSD11
|
major facilitator superfamily domain containing 11 |
chr10_+_76871454 | 12.64 |
ENST00000372687.4
|
SAMD8
|
sterile alpha motif domain containing 8 |
chr16_+_222846 | 12.36 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr14_-_89878369 | 12.34 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
chr11_-_125366089 | 12.21 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
chr11_+_28129795 | 12.18 |
ENST00000406787.3
ENST00000342303.5 ENST00000403099.1 ENST00000407364.3 |
METTL15
|
methyltransferase like 15 |
chr4_+_48018781 | 12.12 |
ENST00000295461.5
|
NIPAL1
|
NIPA-like domain containing 1 |
chr1_-_27961720 | 11.88 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr19_+_42817527 | 11.86 |
ENST00000598766.1
|
TMEM145
|
transmembrane protein 145 |
chr14_-_106622419 | 11.79 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
chr3_-_48057890 | 11.72 |
ENST00000434267.1
|
MAP4
|
microtubule-associated protein 4 |
chr7_+_102715315 | 11.72 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
chr3_+_10206545 | 11.71 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr22_-_45559642 | 11.66 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr1_+_160085501 | 11.63 |
ENST00000361216.3
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr1_+_160097462 | 11.52 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chrX_-_50557014 | 11.37 |
ENST00000376020.2
|
SHROOM4
|
shroom family member 4 |
chr11_+_62475130 | 11.35 |
ENST00000294117.5
|
GNG3
|
guanine nucleotide binding protein (G protein), gamma 3 |
chr6_+_32407619 | 11.17 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr19_+_36195467 | 11.13 |
ENST00000426659.2
|
ZBTB32
|
zinc finger and BTB domain containing 32 |
chr16_+_67840986 | 11.09 |
ENST00000561639.1
ENST00000567852.1 ENST00000565148.1 ENST00000388833.3 ENST00000561654.1 ENST00000431934.2 |
TSNAXIP1
|
translin-associated factor X interacting protein 1 |
chr20_-_35492048 | 11.09 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
chr11_+_2421718 | 11.04 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr2_+_89999259 | 11.03 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr6_-_46459099 | 11.00 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr14_-_106963409 | 10.97 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr22_+_22930626 | 10.97 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
chr17_+_1665345 | 10.97 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr22_+_23264766 | 10.88 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chrX_-_50557302 | 10.83 |
ENST00000289292.7
|
SHROOM4
|
shroom family member 4 |
chr3_-_195310802 | 10.79 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr19_+_58095501 | 10.78 |
ENST00000536878.2
ENST00000597850.1 ENST00000597219.1 ENST00000598689.1 ENST00000599456.1 ENST00000307468.4 |
ZIK1
|
zinc finger protein interacting with K protein 1 |
chr19_-_49828438 | 10.75 |
ENST00000454748.3
ENST00000598828.1 ENST00000335875.4 |
SLC6A16
|
solute carrier family 6, member 16 |
chrX_-_13956737 | 10.75 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
chr21_+_41239243 | 10.70 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
chr6_+_111580508 | 10.62 |
ENST00000368847.4
|
KIAA1919
|
KIAA1919 |
chr7_-_87505658 | 10.54 |
ENST00000341119.5
|
SLC25A40
|
solute carrier family 25, member 40 |
chr5_-_149792295 | 10.53 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr4_-_57522598 | 10.44 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr11_+_117857063 | 10.44 |
ENST00000227752.3
ENST00000541785.1 ENST00000545409.1 |
IL10RA
|
interleukin 10 receptor, alpha |
chr22_+_22786288 | 10.40 |
ENST00000390301.2
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr1_+_111773349 | 10.34 |
ENST00000533831.2
|
CHI3L2
|
chitinase 3-like 2 |
chr11_+_1891380 | 10.33 |
ENST00000429923.1
ENST00000418975.1 ENST00000406638.2 |
LSP1
|
lymphocyte-specific protein 1 |
chr4_-_57522673 | 10.32 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr2_-_89399845 | 10.30 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr16_+_67840668 | 10.29 |
ENST00000415766.3
|
TSNAXIP1
|
translin-associated factor X interacting protein 1 |
chr19_-_15529790 | 10.29 |
ENST00000596195.1
ENST00000595067.1 ENST00000595465.2 ENST00000397410.5 ENST00000600247.1 |
AKAP8L
|
A kinase (PRKA) anchor protein 8-like |
chr6_-_41701581 | 10.19 |
ENST00000394283.1
|
TFEB
|
transcription factor EB |
chr11_+_62439126 | 10.17 |
ENST00000377953.3
|
C11orf83
|
chromosome 11 open reading frame 83 |
chr2_-_89619904 | 10.15 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr17_-_2415169 | 10.13 |
ENST00000263092.6
ENST00000538844.1 ENST00000576976.1 |
METTL16
|
methyltransferase like 16 |
chr5_-_79551838 | 10.12 |
ENST00000509193.1
ENST00000512972.2 |
SERINC5
|
serine incorporator 5 |
chr5_-_127418755 | 10.11 |
ENST00000501702.2
ENST00000501173.2 ENST00000514573.1 ENST00000499346.2 ENST00000606251.1 |
CTC-228N24.3
|
CTC-228N24.3 |
chr15_-_43941023 | 10.10 |
ENST00000432420.1
ENST00000321596.5 ENST00000354127.4 ENST00000355438.2 ENST00000396879.1 ENST00000381761.1 |
CATSPER2
|
cation channel, sperm associated 2 |
chr1_-_182360498 | 10.10 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
chr7_+_156742399 | 10.09 |
ENST00000275820.3
|
NOM1
|
nucleolar protein with MIF4G domain 1 |
chr6_-_32908765 | 10.07 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
chr2_-_85839146 | 10.05 |
ENST00000306336.5
ENST00000409734.3 |
C2orf68
|
chromosome 2 open reading frame 68 |
chr14_-_106539557 | 10.03 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr14_-_21493884 | 10.03 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr20_+_5892037 | 9.96 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
chr2_-_99224915 | 9.95 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
chr15_-_48470558 | 9.94 |
ENST00000324324.7
|
MYEF2
|
myelin expression factor 2 |
chr2_-_89157161 | 9.90 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
chr1_+_33352036 | 9.89 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
chr7_+_30951461 | 9.89 |
ENST00000311813.4
|
AQP1
|
aquaporin 1 (Colton blood group) |
chr12_+_106696581 | 9.86 |
ENST00000547153.1
ENST00000299045.3 ENST00000546625.1 ENST00000553098.1 |
TCP11L2
|
t-complex 11, testis-specific-like 2 |
chr8_+_21912328 | 9.78 |
ENST00000432128.1
ENST00000443491.2 ENST00000517600.1 ENST00000523782.2 |
DMTN
|
dematin actin binding protein |
chr1_-_32210275 | 9.76 |
ENST00000440175.2
|
BAI2
|
brain-specific angiogenesis inhibitor 2 |
chr3_+_156544057 | 9.75 |
ENST00000498839.1
ENST00000470811.1 ENST00000356539.4 ENST00000483177.1 ENST00000477399.1 ENST00000491763.1 |
LEKR1
|
leucine, glutamate and lysine rich 1 |
chr3_-_58563094 | 9.75 |
ENST00000464064.1
|
FAM107A
|
family with sequence similarity 107, member A |
chr10_+_43916052 | 9.74 |
ENST00000442526.2
|
RP11-517P14.2
|
RP11-517P14.2 |
chr1_+_159175201 | 9.73 |
ENST00000368121.2
|
DARC
|
Duffy blood group, atypical chemokine receptor |
chr3_-_169899504 | 9.69 |
ENST00000474275.1
ENST00000484931.1 ENST00000494943.1 ENST00000497658.1 ENST00000465896.1 ENST00000475729.1 ENST00000495893.2 ENST00000481639.1 ENST00000467570.1 ENST00000466189.1 |
PHC3
|
polyhomeotic homolog 3 (Drosophila) |
chr12_-_51717948 | 9.68 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
chr11_+_113258495 | 9.66 |
ENST00000303941.3
|
ANKK1
|
ankyrin repeat and kinase domain containing 1 |
chr19_+_57831829 | 9.63 |
ENST00000321545.4
|
ZNF543
|
zinc finger protein 543 |
chr5_+_55033845 | 9.60 |
ENST00000353507.5
ENST00000514278.2 ENST00000505374.1 ENST00000506511.1 |
DDX4
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 |
chr3_+_57541975 | 9.56 |
ENST00000487257.1
ENST00000311180.8 |
PDE12
|
phosphodiesterase 12 |
chr19_-_2702681 | 9.55 |
ENST00000382159.3
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7 |
chr20_+_46130619 | 9.54 |
ENST00000372004.3
|
NCOA3
|
nuclear receptor coactivator 3 |
chr20_+_55904815 | 9.54 |
ENST00000371263.3
ENST00000345868.4 ENST00000371260.4 ENST00000418127.1 |
SPO11
|
SPO11 meiotic protein covalently bound to DSB |
chr19_+_36195429 | 9.46 |
ENST00000392197.2
|
ZBTB32
|
zinc finger and BTB domain containing 32 |
chr3_-_138763734 | 9.45 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
chr19_+_49838653 | 9.45 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr14_-_21270995 | 9.43 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_+_6845384 | 9.41 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr1_-_226111929 | 9.39 |
ENST00000343818.6
ENST00000432920.2 |
PYCR2
RP4-559A3.7
|
pyrroline-5-carboxylate reductase family, member 2 Uncharacterized protein |
chr12_-_51717875 | 9.36 |
ENST00000604560.1
|
BIN2
|
bridging integrator 2 |
chr3_-_39322728 | 9.35 |
ENST00000541347.1
ENST00000412814.1 |
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
chr2_-_100939195 | 9.33 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
chr2_-_89292422 | 9.32 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr12_-_53601055 | 9.32 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
chr8_-_120685608 | 9.32 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
chr3_+_197476621 | 9.30 |
ENST00000241502.4
|
FYTTD1
|
forty-two-three domain containing 1 |
chr8_-_38386175 | 9.28 |
ENST00000437935.2
ENST00000358138.1 |
C8orf86
|
chromosome 8 open reading frame 86 |
chr22_+_22712087 | 9.27 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr8_+_21916680 | 9.27 |
ENST00000358242.3
ENST00000415253.1 |
DMTN
|
dematin actin binding protein |
chr21_+_27011584 | 9.25 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr20_-_47894936 | 9.21 |
ENST00000371754.4
|
ZNFX1
|
zinc finger, NFX1-type containing 1 |
chr3_+_9404526 | 9.21 |
ENST00000452837.2
ENST00000417036.1 ENST00000419437.1 ENST00000345094.3 ENST00000515662.2 |
THUMPD3
|
THUMP domain containing 3 |
chr16_-_11370330 | 9.19 |
ENST00000241808.4
ENST00000435245.2 |
PRM2
|
protamine 2 |
chr14_-_106642049 | 9.17 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr13_+_114567131 | 9.13 |
ENST00000608651.1
|
GAS6-AS2
|
GAS6 antisense RNA 2 (head to head) |
chr2_-_220110187 | 9.12 |
ENST00000295759.7
ENST00000392089.2 |
GLB1L
|
galactosidase, beta 1-like |
chr2_-_68384603 | 9.11 |
ENST00000406245.2
ENST00000409164.1 ENST00000295121.6 |
WDR92
|
WD repeat domain 92 |
chr19_-_54327542 | 9.10 |
ENST00000391775.3
ENST00000324134.6 ENST00000535162.1 ENST00000351894.4 ENST00000354278.3 ENST00000391773.1 ENST00000345770.5 ENST00000391772.1 |
NLRP12
|
NLR family, pyrin domain containing 12 |
chr6_-_44281043 | 9.07 |
ENST00000244571.4
|
AARS2
|
alanyl-tRNA synthetase 2, mitochondrial |
chr1_+_183441500 | 9.07 |
ENST00000456731.2
|
SMG7
|
SMG7 nonsense mediated mRNA decay factor |
chr11_+_71791849 | 9.07 |
ENST00000423494.2
ENST00000539587.1 ENST00000538478.1 ENST00000324866.7 ENST00000439209.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr9_-_124132483 | 9.04 |
ENST00000286713.2
ENST00000538954.1 ENST00000347359.2 |
STOM
|
stomatin |
chr5_-_131132614 | 9.03 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
chr6_-_31514333 | 9.03 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr17_+_17942594 | 9.01 |
ENST00000268719.4
|
GID4
|
GID complex subunit 4 |
chr9_+_130159409 | 9.00 |
ENST00000373371.3
|
SLC2A8
|
solute carrier family 2 (facilitated glucose transporter), member 8 |
chr11_-_6440624 | 9.00 |
ENST00000311051.3
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
chr10_+_126150369 | 8.99 |
ENST00000392757.4
ENST00000368842.5 ENST00000368839.1 |
LHPP
|
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
chr12_-_51717922 | 8.99 |
ENST00000452142.2
|
BIN2
|
bridging integrator 2 |
chr8_+_21916710 | 8.97 |
ENST00000523266.1
ENST00000519907.1 |
DMTN
|
dematin actin binding protein |
chr3_-_16646949 | 8.96 |
ENST00000399444.2
|
DAZL
|
deleted in azoospermia-like |
chr19_-_17185848 | 8.90 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
chr14_-_21491477 | 8.90 |
ENST00000298684.5
ENST00000557169.1 ENST00000553563.1 |
NDRG2
|
NDRG family member 2 |
chr1_+_27561104 | 8.89 |
ENST00000361771.3
|
WDTC1
|
WD and tetratricopeptide repeats 1 |
chr22_-_19512893 | 8.87 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr6_-_152639479 | 8.86 |
ENST00000356820.4
|
SYNE1
|
spectrin repeat containing, nuclear envelope 1 |
chr8_-_27457494 | 8.82 |
ENST00000521770.1
|
CLU
|
clusterin |
chr2_-_32390801 | 8.79 |
ENST00000608489.1
|
RP11-563N4.1
|
RP11-563N4.1 |
chr1_+_100598691 | 8.76 |
ENST00000370143.1
ENST00000370141.2 |
TRMT13
|
tRNA methyltransferase 13 homolog (S. cerevisiae) |
chr2_-_70418032 | 8.76 |
ENST00000425268.1
ENST00000428751.1 ENST00000417203.1 ENST00000417865.1 ENST00000428010.1 ENST00000447804.1 ENST00000264434.2 |
C2orf42
|
chromosome 2 open reading frame 42 |
chr12_-_51718436 | 8.75 |
ENST00000544402.1
|
BIN2
|
bridging integrator 2 |
chr2_-_62081254 | 8.70 |
ENST00000405894.3
|
FAM161A
|
family with sequence similarity 161, member A |
chr8_+_28747884 | 8.68 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
chr19_+_3178736 | 8.67 |
ENST00000246115.3
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
chr22_+_23134974 | 8.66 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr1_+_160765947 | 8.65 |
ENST00000263285.6
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
chr4_-_153456153 | 8.63 |
ENST00000603548.1
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr6_-_31514516 | 8.63 |
ENST00000303892.5
ENST00000483251.1 |
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr14_-_106054659 | 8.60 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr9_-_139094988 | 8.59 |
ENST00000371746.3
|
LHX3
|
LIM homeobox 3 |
chr6_-_99873145 | 8.58 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
chr8_+_24771265 | 8.57 |
ENST00000518131.1
ENST00000437366.2 |
NEFM
|
neurofilament, medium polypeptide |
chr17_-_27278304 | 8.56 |
ENST00000577226.1
|
PHF12
|
PHD finger protein 12 |
chr14_-_81687197 | 8.55 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr2_-_62733476 | 8.53 |
ENST00000335390.5
|
TMEM17
|
transmembrane protein 17 |
chr20_+_44563267 | 8.53 |
ENST00000372409.3
|
PCIF1
|
PDX1 C-terminal inhibiting factor 1 |
chr19_+_49866851 | 8.50 |
ENST00000221498.2
ENST00000596402.1 |
DKKL1
|
dickkopf-like 1 |
chr19_+_5623186 | 8.50 |
ENST00000538656.1
|
SAFB
|
scaffold attachment factor B |
chr6_+_142468361 | 8.47 |
ENST00000367630.4
|
VTA1
|
vesicle (multivesicular body) trafficking 1 |
chr11_+_57365150 | 8.47 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr12_+_6930703 | 8.46 |
ENST00000311268.3
|
GPR162
|
G protein-coupled receptor 162 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.7 | 30.8 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
7.5 | 7.5 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
7.2 | 36.1 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
6.8 | 27.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
6.4 | 19.3 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
6.4 | 38.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
6.3 | 6.3 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
6.3 | 25.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
6.1 | 18.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
5.9 | 17.7 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
5.5 | 5.5 | GO:0045937 | positive regulation of phosphorus metabolic process(GO:0010562) positive regulation of phosphate metabolic process(GO:0045937) |
5.5 | 5.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
5.4 | 16.1 | GO:1904647 | response to rotenone(GO:1904647) |
5.2 | 15.6 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
5.0 | 5.0 | GO:1901739 | regulation of myoblast fusion(GO:1901739) |
4.9 | 4.9 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
4.7 | 14.2 | GO:0034227 | tRNA thio-modification(GO:0034227) |
4.7 | 32.9 | GO:0010958 | regulation of amino acid import(GO:0010958) |
4.6 | 13.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
4.6 | 83.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
4.6 | 32.3 | GO:0035624 | receptor transactivation(GO:0035624) |
4.4 | 13.2 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
4.2 | 4.2 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
4.2 | 12.6 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
4.2 | 25.0 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
4.0 | 12.0 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
4.0 | 59.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.8 | 11.4 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
3.7 | 3.7 | GO:0060022 | hard palate development(GO:0060022) |
3.7 | 7.3 | GO:0070374 | positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
3.6 | 18.2 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
3.6 | 3.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
3.6 | 10.8 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.5 | 14.2 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
3.5 | 17.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
3.5 | 7.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
3.5 | 3.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
3.4 | 3.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
3.4 | 10.2 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
3.4 | 17.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.3 | 19.9 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
3.3 | 13.2 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
3.3 | 3.3 | GO:0031297 | replication fork processing(GO:0031297) |
3.2 | 9.7 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
3.2 | 6.4 | GO:0009636 | response to toxic substance(GO:0009636) |
3.2 | 9.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
3.2 | 12.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
3.2 | 25.3 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
3.1 | 9.3 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
3.1 | 6.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
3.0 | 12.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
3.0 | 9.0 | GO:2000777 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
3.0 | 8.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
2.9 | 5.9 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
2.9 | 2.9 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.9 | 11.6 | GO:1902075 | cellular response to salt(GO:1902075) |
2.9 | 8.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.9 | 8.6 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
2.9 | 2.9 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
2.8 | 2.8 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
2.8 | 14.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
2.8 | 400.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.8 | 11.2 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
2.8 | 8.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.8 | 11.1 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
2.7 | 11.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
2.7 | 13.7 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
2.7 | 10.9 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
2.7 | 8.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
2.7 | 10.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
2.7 | 8.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
2.7 | 8.0 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
2.7 | 8.0 | GO:0071168 | protein localization to chromatin(GO:0071168) |
2.7 | 8.0 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.7 | 2.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.6 | 10.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.6 | 7.9 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.6 | 13.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.6 | 7.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
2.6 | 2.6 | GO:0034694 | response to prostaglandin(GO:0034694) |
2.6 | 7.7 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
2.6 | 5.1 | GO:0002434 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
2.6 | 20.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.6 | 20.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.6 | 7.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
2.6 | 7.7 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
2.5 | 7.6 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
2.5 | 12.7 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.5 | 10.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
2.5 | 10.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
2.5 | 25.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.5 | 12.4 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
2.4 | 4.9 | GO:0007418 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
2.4 | 16.9 | GO:0045007 | depurination(GO:0045007) |
2.4 | 9.6 | GO:0021633 | optic nerve structural organization(GO:0021633) |
2.4 | 2.4 | GO:0072560 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
2.4 | 33.4 | GO:0015671 | oxygen transport(GO:0015671) |
2.4 | 11.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
2.4 | 7.1 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
2.4 | 7.1 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
2.4 | 14.1 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
2.3 | 7.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
2.3 | 2.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
2.3 | 7.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
2.3 | 6.9 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
2.3 | 4.6 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
2.3 | 13.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.3 | 2.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
2.3 | 6.8 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
2.3 | 13.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
2.2 | 13.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
2.2 | 11.2 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
2.2 | 6.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
2.2 | 6.6 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.2 | 8.8 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
2.2 | 8.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
2.2 | 4.4 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
2.2 | 8.7 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.1 | 4.3 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
2.1 | 6.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
2.1 | 6.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
2.1 | 48.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
2.1 | 8.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
2.1 | 10.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.1 | 10.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
2.1 | 35.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
2.1 | 6.2 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
2.1 | 2.1 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
2.1 | 2.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
2.1 | 24.6 | GO:1902548 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
2.0 | 8.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.0 | 18.4 | GO:0015747 | urate transport(GO:0015747) |
2.0 | 10.1 | GO:0080009 | mRNA methylation(GO:0080009) |
2.0 | 6.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.0 | 6.0 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
2.0 | 4.0 | GO:0006473 | protein acetylation(GO:0006473) |
2.0 | 5.9 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
2.0 | 3.9 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
2.0 | 11.7 | GO:0051012 | microtubule sliding(GO:0051012) |
2.0 | 7.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.9 | 9.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.9 | 5.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.9 | 3.9 | GO:1904306 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
1.9 | 1.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.9 | 5.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.9 | 1.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
1.9 | 15.3 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.9 | 3.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.9 | 19.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.9 | 1.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
1.9 | 5.7 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
1.9 | 13.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.9 | 11.3 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
1.9 | 9.3 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
1.9 | 1.9 | GO:0045056 | transcytosis(GO:0045056) |
1.9 | 7.4 | GO:0033590 | response to cobalamin(GO:0033590) |
1.9 | 5.6 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.8 | 7.4 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
1.8 | 5.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.8 | 5.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.8 | 3.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.8 | 10.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.8 | 23.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.8 | 3.6 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
1.8 | 5.4 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.8 | 8.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
1.8 | 3.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.8 | 3.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.8 | 28.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.8 | 3.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.7 | 7.0 | GO:0048241 | epinephrine transport(GO:0048241) |
1.7 | 3.5 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.7 | 5.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.7 | 5.1 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
1.7 | 3.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.7 | 5.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.7 | 30.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.7 | 5.1 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
1.7 | 1.7 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
1.7 | 3.4 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
1.7 | 6.7 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
1.7 | 18.5 | GO:0033227 | dsRNA transport(GO:0033227) |
1.7 | 11.8 | GO:0030279 | negative regulation of ossification(GO:0030279) |
1.7 | 3.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.7 | 5.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.7 | 6.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
1.7 | 3.3 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
1.7 | 8.3 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
1.6 | 6.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
1.6 | 14.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.6 | 3.3 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.6 | 4.9 | GO:1990502 | dense core granule maturation(GO:1990502) |
1.6 | 11.3 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.6 | 3.2 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
1.6 | 11.2 | GO:0034644 | cellular response to UV(GO:0034644) |
1.6 | 3.2 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.6 | 4.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.6 | 1.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.6 | 4.8 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.6 | 19.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.6 | 4.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.6 | 9.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.6 | 4.7 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
1.6 | 14.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
1.6 | 12.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.6 | 6.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.6 | 3.1 | GO:0001556 | oocyte maturation(GO:0001556) |
1.6 | 1.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
1.6 | 4.7 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
1.6 | 4.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.6 | 23.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.6 | 4.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
1.6 | 4.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
1.6 | 9.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
1.6 | 4.7 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.6 | 4.7 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.5 | 4.6 | GO:0035878 | nail development(GO:0035878) |
1.5 | 4.6 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
1.5 | 6.2 | GO:0021914 | signal transduction downstream of smoothened(GO:0007227) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) intraciliary anterograde transport(GO:0035720) |
1.5 | 9.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.5 | 1.5 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
1.5 | 3.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
1.5 | 3.0 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
1.5 | 7.6 | GO:0097338 | response to clozapine(GO:0097338) |
1.5 | 6.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.5 | 4.5 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
1.5 | 1.5 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
1.5 | 4.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
1.5 | 4.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.5 | 4.4 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
1.5 | 4.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.5 | 1.5 | GO:0051085 | 'de novo' posttranslational protein folding(GO:0051084) chaperone mediated protein folding requiring cofactor(GO:0051085) |
1.5 | 14.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.5 | 1.5 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
1.5 | 23.5 | GO:0044117 | growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) |
1.5 | 7.3 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
1.5 | 1.5 | GO:0046645 | positive regulation of gamma-delta T cell activation(GO:0046645) |
1.5 | 7.3 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
1.5 | 5.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.5 | 2.9 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
1.5 | 7.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
1.5 | 10.2 | GO:0009597 | detection of virus(GO:0009597) |
1.5 | 7.3 | GO:0030070 | insulin processing(GO:0030070) |
1.4 | 5.8 | GO:0051026 | chiasma assembly(GO:0051026) |
1.4 | 18.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.4 | 7.2 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.4 | 8.6 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 5.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.4 | 17.1 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
1.4 | 4.3 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
1.4 | 4.3 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.4 | 2.8 | GO:2000364 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
1.4 | 25.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.4 | 4.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.4 | 11.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
1.4 | 11.2 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.4 | 27.7 | GO:0097320 | membrane tubulation(GO:0097320) |
1.4 | 9.7 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.4 | 4.2 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.4 | 1.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.4 | 9.6 | GO:0050718 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
1.4 | 4.1 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
1.4 | 8.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
1.4 | 5.5 | GO:1901727 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
1.4 | 2.7 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
1.4 | 11.0 | GO:0034465 | response to carbon monoxide(GO:0034465) |
1.4 | 5.5 | GO:0048749 | compound eye development(GO:0048749) |
1.4 | 2.7 | GO:0048867 | stem cell fate determination(GO:0048867) |
1.4 | 9.5 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.3 | 4.0 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
1.3 | 4.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.3 | 5.4 | GO:0030242 | pexophagy(GO:0030242) |
1.3 | 4.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.3 | 1.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.3 | 1.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.3 | 2.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.3 | 1.3 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
1.3 | 34.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
1.3 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
1.3 | 25.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
1.3 | 3.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.3 | 2.6 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
1.3 | 3.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
1.3 | 9.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.3 | 15.4 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.3 | 2.6 | GO:0048865 | stem cell fate commitment(GO:0048865) |
1.3 | 11.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.3 | 3.8 | GO:0071529 | cementum mineralization(GO:0071529) |
1.3 | 7.6 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
1.3 | 7.6 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
1.3 | 2.5 | GO:0072237 | metanephric proximal tubule development(GO:0072237) |
1.3 | 3.8 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
1.3 | 5.0 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
1.3 | 8.8 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
1.3 | 7.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.2 | 13.7 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.2 | 10.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.2 | 7.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.2 | 1.2 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.2 | 2.4 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
1.2 | 6.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
1.2 | 6.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.2 | 4.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.2 | 14.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.2 | 4.8 | GO:0045575 | basophil activation(GO:0045575) |
1.2 | 6.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.2 | 3.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.2 | 4.8 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
1.2 | 1.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
1.2 | 4.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.2 | 3.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
1.2 | 5.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
1.2 | 1.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.2 | 3.5 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
1.2 | 15.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.2 | 5.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
1.2 | 2.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.2 | 13.9 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.2 | 5.8 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.1 | 3.4 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.1 | 4.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.1 | 4.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
1.1 | 9.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.1 | 3.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
1.1 | 2.3 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
1.1 | 1.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.1 | 15.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.1 | 2.2 | GO:0043967 | histone H4 acetylation(GO:0043967) |
1.1 | 10.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
1.1 | 4.5 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
1.1 | 4.5 | GO:0019046 | release from viral latency(GO:0019046) |
1.1 | 2.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
1.1 | 3.3 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.1 | 2.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.1 | 16.6 | GO:0007141 | male meiosis I(GO:0007141) |
1.1 | 4.4 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.1 | 4.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 3.3 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
1.1 | 6.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.1 | 16.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.1 | 7.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.1 | 5.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.1 | 2.2 | GO:0003051 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) |
1.1 | 3.2 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.1 | 3.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
1.1 | 4.3 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
1.1 | 5.4 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
1.1 | 3.2 | GO:1901374 | acetate ester transport(GO:1901374) |
1.1 | 8.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.1 | 13.9 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
1.1 | 3.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
1.1 | 7.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
1.1 | 6.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.1 | 7.5 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
1.1 | 1.1 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
1.1 | 1.1 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.1 | 3.2 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
1.1 | 4.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.0 | 3.1 | GO:0015819 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
1.0 | 3.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
1.0 | 12.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.0 | 12.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
1.0 | 5.2 | GO:0035936 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
1.0 | 11.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.0 | 2.1 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
1.0 | 8.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.0 | 2.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.0 | 12.4 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.0 | 3.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.0 | 5.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.0 | 3.1 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.0 | 10.3 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 3.1 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.0 | 3.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
1.0 | 6.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.0 | 1.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.0 | 3.1 | GO:0010452 | histone H3-K36 methylation(GO:0010452) histone H3-K36 dimethylation(GO:0097676) |
1.0 | 2.0 | GO:0060023 | soft palate development(GO:0060023) |
1.0 | 8.1 | GO:0015705 | iodide transport(GO:0015705) |
1.0 | 15.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.0 | 17.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.0 | 2.0 | GO:0002215 | defense response to nematode(GO:0002215) |
1.0 | 3.0 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
1.0 | 3.0 | GO:1902996 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
1.0 | 4.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
1.0 | 4.0 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
1.0 | 5.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.0 | 2.0 | GO:0021834 | embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
1.0 | 2.0 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
1.0 | 15.8 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
1.0 | 4.0 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
1.0 | 12.8 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.0 | 2.9 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
1.0 | 2.0 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
1.0 | 6.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
1.0 | 2.0 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
1.0 | 2.9 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
1.0 | 5.9 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
1.0 | 4.9 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.0 | 2.9 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
1.0 | 6.8 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.0 | 2.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
1.0 | 9.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 2.9 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
1.0 | 2.9 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
1.0 | 4.8 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
1.0 | 1.9 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
0.9 | 2.8 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.9 | 3.8 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.9 | 7.6 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.9 | 11.3 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.9 | 2.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.9 | 6.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.9 | 7.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.9 | 1.9 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
0.9 | 2.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.9 | 5.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.9 | 2.8 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.9 | 12.0 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.9 | 1.8 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.9 | 7.4 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.9 | 4.6 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.9 | 2.8 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.9 | 0.9 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.9 | 4.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.9 | 3.6 | GO:0061743 | motor learning(GO:0061743) |
0.9 | 3.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.9 | 3.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.9 | 4.5 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) Harderian gland development(GO:0070384) |
0.9 | 5.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.9 | 3.6 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.9 | 12.5 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.9 | 4.4 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.9 | 1.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.9 | 2.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.9 | 1.8 | GO:0042116 | macrophage activation(GO:0042116) |
0.9 | 2.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.9 | 3.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.9 | 4.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.9 | 2.6 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.9 | 3.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.9 | 0.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.9 | 4.4 | GO:0090197 | positive regulation of chemokine secretion(GO:0090197) |
0.9 | 0.9 | GO:1905064 | negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
0.9 | 6.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.9 | 1.7 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.9 | 1.7 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.9 | 1.7 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.9 | 5.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.9 | 6.0 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.9 | 2.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 1.7 | GO:0021586 | pons maturation(GO:0021586) |
0.9 | 1.7 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.9 | 6.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.9 | 1.7 | GO:0007412 | axon target recognition(GO:0007412) |
0.8 | 2.5 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.8 | 12.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 5.9 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
0.8 | 5.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.8 | 2.5 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.8 | 5.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.8 | 5.1 | GO:0032328 | alanine transport(GO:0032328) |
0.8 | 16.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 2.5 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.8 | 5.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 2.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.8 | 3.3 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.8 | 7.4 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.8 | 4.9 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.8 | 3.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.8 | 4.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.8 | 2.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.8 | 1.6 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.8 | 2.4 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.8 | 4.0 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.8 | 6.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 5.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.8 | 1.6 | GO:0045165 | cell fate commitment(GO:0045165) |
0.8 | 1.6 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.8 | 2.4 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.8 | 3.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.8 | 1.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 3.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.8 | 1.6 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.8 | 5.5 | GO:0021794 | thalamus development(GO:0021794) |
0.8 | 3.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.8 | 3.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.8 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 6.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 3.9 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.8 | 6.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 4.6 | GO:0019835 | cytolysis(GO:0019835) |
0.8 | 5.4 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.8 | 13.1 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.8 | 8.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.8 | 3.8 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.8 | 4.6 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.8 | 3.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.8 | 3.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.8 | 2.3 | GO:0070781 | response to biotin(GO:0070781) |
0.7 | 1.5 | GO:0019751 | polyol metabolic process(GO:0019751) |
0.7 | 2.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.7 | 8.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.7 | 5.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 4.5 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.7 | 11.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.7 | 5.2 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.7 | 0.7 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.7 | 2.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.7 | 6.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.7 | 14.6 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 2.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.7 | 2.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.7 | 5.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 8.0 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.7 | 2.9 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.7 | 2.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.7 | 2.9 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.7 | 3.6 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.7 | 10.0 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.7 | 6.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 9.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.7 | 9.3 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.7 | 6.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.7 | 3.5 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.7 | 7.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.7 | 4.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.7 | 4.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 2.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.7 | 4.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.7 | 2.1 | GO:0061304 | extracellular matrix-cell signaling(GO:0035426) retinal blood vessel morphogenesis(GO:0061304) |
0.7 | 2.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.7 | 4.2 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.7 | 4.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.7 | 16.6 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.7 | 4.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.7 | 26.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.7 | 4.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.7 | 2.0 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.7 | 4.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.7 | 3.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.7 | 2.7 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.7 | 2.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.7 | 4.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.7 | 7.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.7 | 0.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.7 | 4.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.7 | 4.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.7 | 34.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.7 | 3.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.7 | 1.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.7 | 13.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.7 | 1.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.7 | 3.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 3.9 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 2.6 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 3.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.6 | 10.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.6 | 1.9 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.6 | 7.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.6 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 3.8 | GO:0010761 | fibroblast migration(GO:0010761) |
0.6 | 2.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.6 | 12.6 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.6 | 1.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.6 | 1.9 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.6 | 7.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 14.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.6 | 1.9 | GO:0007538 | primary sex determination(GO:0007538) |
0.6 | 2.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.6 | 4.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.6 | 4.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.6 | 3.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.6 | 2.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 9.2 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.6 | 3.7 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.6 | 3.7 | GO:0042048 | olfactory behavior(GO:0042048) |
0.6 | 2.4 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 6.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.6 | 3.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.6 | 2.4 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.6 | 7.8 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.6 | 6.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.6 | 4.2 | GO:0001554 | luteolysis(GO:0001554) |
0.6 | 9.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 2.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.6 | 1.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.6 | 1.8 | GO:0002118 | aggressive behavior(GO:0002118) |
0.6 | 4.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.6 | 7.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 3.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.6 | 1.8 | GO:0036314 | response to sterol(GO:0036314) |
0.6 | 21.9 | GO:0030317 | sperm motility(GO:0030317) |
0.6 | 1.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.6 | 2.3 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.6 | 4.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 1.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.6 | 6.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.6 | 15.7 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.6 | 2.9 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.6 | 5.8 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.6 | 4.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.6 | 1.7 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.6 | 1.7 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.6 | 2.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.6 | 1.7 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.6 | 0.6 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 | 7.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.6 | 2.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.6 | 6.8 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.6 | 1.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.6 | 3.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.6 | 3.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.6 | 2.8 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.6 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 3.9 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.6 | 5.0 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.6 | 1.7 | GO:0009409 | response to cold(GO:0009409) |
0.6 | 5.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.6 | 2.2 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.6 | 3.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.5 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.5 | 1.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.5 | 6.0 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.5 | 37.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.5 | 3.8 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.5 | 9.2 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.5 | 4.9 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.5 | 6.5 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.5 | 11.3 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.5 | 4.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.5 | 5.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.5 | 4.8 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.5 | 9.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.5 | 2.7 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.5 | 4.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 2.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 5.3 | GO:0006833 | water transport(GO:0006833) |
0.5 | 2.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.5 | 9.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.5 | 11.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 2.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.5 | 11.5 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.5 | 10.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 1.0 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.5 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 16.7 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.5 | 0.5 | GO:0042698 | ovulation cycle(GO:0042698) |
0.5 | 2.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 2.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.5 | 1.6 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
0.5 | 1.0 | GO:0021707 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.5 | 2.6 | GO:0035799 | ureter maturation(GO:0035799) |
0.5 | 2.6 | GO:0007320 | insemination(GO:0007320) |
0.5 | 4.1 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.5 | 1.5 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.5 | 12.7 | GO:0090314 | positive regulation of protein targeting to membrane(GO:0090314) |
0.5 | 12.6 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.5 | 10.0 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.5 | 5.0 | GO:0086067 | AV node cell to bundle of His cell communication(GO:0086067) |
0.5 | 20.4 | GO:1901998 | toxin transport(GO:1901998) |
0.5 | 3.4 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.5 | 2.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.5 | 2.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.5 | 1.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.5 | 1.5 | GO:1990834 | response to odorant(GO:1990834) |
0.5 | 3.4 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.5 | 10.7 | GO:0050779 | RNA destabilization(GO:0050779) |
0.5 | 11.2 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.5 | 3.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.5 | 0.5 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
0.5 | 3.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 1.5 | GO:0044818 | mitotic G2 DNA damage checkpoint(GO:0007095) mitotic G2/M transition checkpoint(GO:0044818) |
0.5 | 12.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.4 | GO:0044728 | DNA methylation or demethylation(GO:0044728) |
0.5 | 1.0 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.5 | 8.2 | GO:0097186 | amelogenesis(GO:0097186) |
0.5 | 1.9 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 1.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 6.7 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.5 | 1.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.5 | 2.4 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
0.5 | 2.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 1.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 2.8 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.5 | 16.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.5 | 3.8 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.5 | 2.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 1.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.5 | 0.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.5 | 2.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.5 | 4.2 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.5 | 0.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.5 | 1.4 | GO:0034505 | tooth mineralization(GO:0034505) |
0.5 | 1.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.5 | 0.9 | GO:0045402 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.5 | 2.7 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.5 | 5.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.5 | 3.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 0.5 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.5 | 11.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.5 | 58.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.4 | 25.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 7.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.4 | 1.8 | GO:0097421 | liver regeneration(GO:0097421) |
0.4 | 5.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 2.6 | GO:0048619 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) hindgut development(GO:0061525) |
0.4 | 4.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 1.8 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 3.5 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.4 | 1.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 7.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.4 | 1.3 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.4 | 1.7 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 2.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.4 | 1.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.4 | 2.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.4 | 1.3 | GO:0098907 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
0.4 | 1.7 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.4 | 1.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.4 | 1.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.4 | 1.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.4 | 1.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 5.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.4 | 1.7 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 2.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.4 | 7.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.4 | 0.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.4 | 1.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.4 | 2.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.4 | 0.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 6.2 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 4.9 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.4 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 3.3 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 0.8 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 4.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 1.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 1.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.4 | 2.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.4 | 2.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.4 | 2.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.4 | 9.5 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.4 | 1.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.4 | 1.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 2.7 | GO:0033622 | integrin activation(GO:0033622) |
0.4 | 3.9 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 | 6.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.4 | 8.2 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.4 | 5.8 | GO:0007628 | adult walking behavior(GO:0007628) |
0.4 | 1.2 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 0.8 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.4 | 3.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.4 | 1.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.4 | 0.8 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.4 | 2.7 | GO:0042426 | choline catabolic process(GO:0042426) |
0.4 | 1.5 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 7.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.4 | 5.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 1.1 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.4 | 3.7 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 0.4 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 1.1 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
0.4 | 7.5 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
0.4 | 1.1 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.4 | 6.4 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 1.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.4 | 3.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 2.8 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.3 | 1.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.3 | 1.4 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.3 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 3.1 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 10.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.3 | 1.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 1.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 4.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 3.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.3 | 1.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.3 | 1.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.3 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 3.0 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.3 | 5.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 4.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.3 | 4.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 2.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 1.7 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.3 | 1.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 2.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 2.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 0.3 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 4.6 | GO:0007398 | ectoderm development(GO:0007398) |
0.3 | 1.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.3 | 0.6 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 1.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.3 | 0.6 | GO:1990036 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.3 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.3 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.3 | 4.7 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.3 | 3.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.6 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.3 | 2.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 2.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.3 | 1.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 1.9 | GO:0002786 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 0.9 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.3 | 0.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 3.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.3 | 1.2 | GO:0015696 | ammonium transport(GO:0015696) |
0.3 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.3 | 2.7 | GO:0050821 | protein stabilization(GO:0050821) |
0.3 | 3.3 | GO:0010224 | response to UV-B(GO:0010224) |
0.3 | 0.6 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.3 | 1.8 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.3 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 2.7 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.3 | 2.1 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.3 | 25.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 2.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.3 | 1.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
0.3 | 0.6 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.3 | 7.1 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 0.9 | GO:0039506 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.3 | 0.3 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 2.3 | GO:0006298 | mismatch repair(GO:0006298) |
0.3 | 2.6 | GO:0030238 | male sex determination(GO:0030238) |
0.3 | 1.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.3 | 1.4 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 2.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 2.0 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 4.0 | GO:0000732 | strand displacement(GO:0000732) |
0.3 | 1.1 | GO:0090313 | regulation of protein targeting to membrane(GO:0090313) |
0.3 | 4.5 | GO:0098743 | cell aggregation(GO:0098743) |
0.3 | 2.8 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.3 | 1.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 5.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 1.9 | GO:0009642 | response to light intensity(GO:0009642) |
0.3 | 1.1 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 3.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.3 | 0.8 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 1.1 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.3 | 1.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.3 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 3.7 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.3 | 1.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 2.1 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.3 | 1.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 2.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.3 | 1.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 3.9 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 4.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 0.7 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 1.2 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.2 | 1.2 | GO:0001660 | fever generation(GO:0001660) |
0.2 | 3.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 1.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 1.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.2 | 2.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.2 | 0.9 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.2 | 1.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 2.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 2.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.2 | 5.6 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 0.5 | GO:0060685 | prostatic bud formation(GO:0060513) regulation of prostatic bud formation(GO:0060685) |
0.2 | 2.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.2 | 0.7 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 1.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 2.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.2 | 1.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 3.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 2.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.9 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 0.4 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.2 | 2.9 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 2.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 2.0 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.2 | 0.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 2.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 1.3 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.2 | 0.4 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.2 | 1.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.9 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.2 | 2.4 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.2 | 2.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 1.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 3.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 0.9 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.2 | 1.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 2.6 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.2 | 2.4 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.2 | 2.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 1.1 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.2 | 1.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 1.9 | GO:0007517 | muscle organ development(GO:0007517) |
0.2 | 2.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.2 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.2 | 2.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 1.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.8 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 1.5 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 2.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 1.0 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.2 | 0.8 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.2 | 1.8 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.2 | 1.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 3.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.2 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 1.2 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.2 | 0.2 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 0.4 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.2 | 3.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.2 | 2.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of myoblast fusion(GO:1901740) |
0.2 | 0.8 | GO:0007281 | germ cell development(GO:0007281) |
0.2 | 1.7 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 5.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.2 | 0.2 | GO:0051347 | positive regulation of transferase activity(GO:0051347) |
0.2 | 6.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 0.4 | GO:1904238 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
0.2 | 1.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 1.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.2 | 2.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.2 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 3.1 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.2 | 0.5 | GO:0006312 | mitotic recombination(GO:0006312) |
0.2 | 0.7 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 4.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 3.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 1.4 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 0.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 1.9 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.2 | 0.9 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.7 | GO:0032218 | riboflavin transport(GO:0032218) |
0.2 | 1.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.7 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.2 | 5.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.3 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 1.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.2 | 3.1 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
0.2 | 0.5 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.2 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 0.5 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.6 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 2.1 | GO:0050671 | positive regulation of lymphocyte proliferation(GO:0050671) |
0.2 | 1.6 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.2 | 1.1 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.2 | 1.3 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.2 | 1.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.6 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.9 | GO:0048536 | spleen development(GO:0048536) |
0.2 | 0.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.2 | 1.4 | GO:0032094 | response to food(GO:0032094) |
0.2 | 1.2 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.2 | 0.6 | GO:0097484 | dendrite extension(GO:0097484) |
0.2 | 3.8 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 19.2 | GO:0007601 | visual perception(GO:0007601) |
0.1 | 4.2 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 2.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.4 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.1 | 7.2 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 1.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 1.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 3.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 1.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 3.4 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.4 | GO:1901978 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 6.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 1.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.3 | GO:0009304 | tRNA transcription(GO:0009304) |
0.1 | 1.6 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.7 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.1 | 3.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 4.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 1.0 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 1.4 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 1.1 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 1.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 1.6 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 1.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.6 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 15.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.6 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 3.9 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.6 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.2 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.1 | 0.3 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 9.7 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 2.6 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.1 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 1.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.2 | GO:0051148 | negative regulation of muscle cell differentiation(GO:0051148) |
0.1 | 1.7 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 2.9 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.3 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
0.1 | 0.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.5 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 1.0 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 1.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.4 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 1.2 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 1.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.5 | GO:0038034 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.1 | 0.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 | 0.5 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 4.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 1.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.8 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 0.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.4 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 4.3 | GO:0007286 | spermatid development(GO:0007286) |
0.1 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.1 | 0.2 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.1 | 0.6 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.1 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.2 | GO:0045425 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 0.6 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 1.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.2 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.2 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.1 | 0.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.0 | 0.9 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.0 | 0.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.0 | 0.6 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.3 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.0 | 0.1 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.4 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.0 | 0.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0022037 | cerebellum development(GO:0021549) metencephalon development(GO:0022037) |
0.0 | 0.6 | GO:0042554 | superoxide anion generation(GO:0042554) |
0.0 | 0.4 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.4 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.0 | 0.1 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.0 | 0.2 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.0 | 0.1 | GO:2000316 | interleukin-18 production(GO:0032621) regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 17 cell differentiation(GO:2000319) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0050927 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
0.0 | 1.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.3 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.2 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.0 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 0.4 | GO:0050890 | cognition(GO:0050890) |
0.0 | 0.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.0 | 0.2 | GO:1900372 | negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
0.0 | 0.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.1 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.9 | 35.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
8.4 | 25.1 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
6.8 | 27.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
4.4 | 21.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
4.4 | 17.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
4.3 | 21.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
3.7 | 78.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.6 | 18.2 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
3.6 | 43.5 | GO:0043203 | axon hillock(GO:0043203) |
3.6 | 14.4 | GO:1990745 | EARP complex(GO:1990745) |
3.5 | 10.4 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
3.3 | 9.9 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
3.2 | 9.6 | GO:0071546 | pi-body(GO:0071546) |
3.2 | 3.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
3.1 | 15.5 | GO:0000801 | central element(GO:0000801) |
3.0 | 21.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
2.9 | 17.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
2.8 | 133.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
2.8 | 33.2 | GO:0033010 | paranodal junction(GO:0033010) |
2.7 | 43.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.6 | 13.2 | GO:0036128 | CatSper complex(GO:0036128) |
2.6 | 18.0 | GO:0033269 | internode region of axon(GO:0033269) |
2.5 | 10.1 | GO:0070695 | FHF complex(GO:0070695) |
2.5 | 52.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.5 | 14.8 | GO:1990130 | Iml1 complex(GO:1990130) |
2.5 | 7.4 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
2.4 | 9.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.4 | 7.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
2.3 | 4.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
2.3 | 11.3 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
2.1 | 6.4 | GO:0044305 | calyx of Held(GO:0044305) |
2.1 | 33.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.1 | 6.2 | GO:0098536 | deuterosome(GO:0098536) |
2.0 | 18.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.9 | 1.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.8 | 18.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.8 | 25.6 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
1.8 | 12.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
1.8 | 5.4 | GO:0044609 | DBIRD complex(GO:0044609) |
1.8 | 10.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.7 | 13.9 | GO:0035976 | AP1 complex(GO:0035976) |
1.7 | 8.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.7 | 6.9 | GO:0032437 | cuticular plate(GO:0032437) |
1.7 | 6.8 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.7 | 1.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
1.6 | 3.2 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.6 | 20.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.6 | 4.8 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
1.6 | 7.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.6 | 4.7 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
1.6 | 7.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.5 | 12.2 | GO:0043196 | varicosity(GO:0043196) |
1.5 | 12.0 | GO:0032010 | phagolysosome(GO:0032010) |
1.5 | 37.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.5 | 10.4 | GO:0072487 | MSL complex(GO:0072487) |
1.5 | 5.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
1.5 | 5.9 | GO:0097224 | sperm connecting piece(GO:0097224) |
1.4 | 17.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.4 | 25.3 | GO:0001891 | phagocytic cup(GO:0001891) |
1.4 | 6.8 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.4 | 5.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.3 | 5.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.3 | 5.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.3 | 15.7 | GO:0031045 | dense core granule(GO:0031045) |
1.3 | 23.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.3 | 3.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.2 | 10.0 | GO:0036157 | outer dynein arm(GO:0036157) |
1.2 | 3.7 | GO:0016938 | kinesin I complex(GO:0016938) |
1.2 | 5.0 | GO:0031417 | NatC complex(GO:0031417) |
1.2 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.2 | 3.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.2 | 4.8 | GO:1990246 | uniplex complex(GO:1990246) |
1.2 | 8.4 | GO:0001520 | outer dense fiber(GO:0001520) |
1.2 | 3.6 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
1.2 | 14.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.1 | 15.8 | GO:0036038 | MKS complex(GO:0036038) |
1.1 | 11.3 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 6.7 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.1 | 13.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.1 | 4.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.1 | 4.4 | GO:1990031 | pinceau fiber(GO:1990031) |
1.1 | 7.7 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 4.4 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.1 | 3.3 | GO:0060187 | cell pole(GO:0060187) |
1.1 | 21.4 | GO:0000242 | pericentriolar material(GO:0000242) |
1.1 | 3.2 | GO:0072534 | perineuronal net(GO:0072534) |
1.1 | 22.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.0 | 2.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.0 | 6.2 | GO:1990037 | Lewy body core(GO:1990037) |
1.0 | 3.1 | GO:0000125 | PCAF complex(GO:0000125) |
1.0 | 2.1 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.0 | 29.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.0 | 6.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
1.0 | 7.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.0 | 2.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.0 | 4.9 | GO:0089701 | U2AF(GO:0089701) |
1.0 | 1.9 | GO:0034657 | GID complex(GO:0034657) |
1.0 | 3.8 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.9 | 8.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.9 | 7.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.9 | 3.6 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.9 | 5.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.9 | 6.2 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.9 | 2.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.9 | 2.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.9 | 14.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.9 | 36.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.9 | 6.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.9 | 11.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 3.4 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.8 | 6.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.8 | 5.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.8 | 7.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.8 | 11.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.8 | 5.7 | GO:0097440 | apical dendrite(GO:0097440) |
0.8 | 20.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.8 | 1.6 | GO:0044308 | axonal spine(GO:0044308) |
0.8 | 2.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.8 | 77.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.8 | 9.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.8 | 3.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 3.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.8 | 2.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.8 | 6.0 | GO:0031931 | TORC1 complex(GO:0031931) |
0.7 | 3.0 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.7 | 38.7 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 3.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.7 | 1.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.7 | 4.3 | GO:0097433 | dense body(GO:0097433) |
0.7 | 7.2 | GO:0043235 | receptor complex(GO:0043235) |
0.7 | 1.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 5.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 11.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.7 | 2.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.7 | 6.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.6 | 9.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.6 | 1.9 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.6 | 9.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.6 | 5.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.6 | 24.3 | GO:0097546 | ciliary base(GO:0097546) |
0.6 | 21.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.6 | 10.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.6 | 19.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.6 | 3.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.6 | 2.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 4.1 | GO:0032590 | dendrite membrane(GO:0032590) |
0.6 | 20.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.6 | 89.9 | GO:0072562 | blood microparticle(GO:0072562) |
0.6 | 1.7 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 3.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.6 | 3.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.6 | 2.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 21.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 8.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.6 | 5.1 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 2.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.6 | 10.1 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 1.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.5 | 4.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 3.2 | GO:0002177 | manchette(GO:0002177) |
0.5 | 2.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.5 | 2.6 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 1.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.5 | 1.6 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
0.5 | 4.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.5 | 3.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.5 | 2.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 2.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.5 | 2.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 1.0 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.5 | 3.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 22.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 8.8 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 53.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 1.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.5 | 7.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 1.5 | GO:0033150 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
0.5 | 6.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.5 | 26.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.5 | 4.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 3.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.5 | 2.4 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.5 | 4.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.5 | 11.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.5 | 5.6 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 66.0 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 4.1 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 4.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 5.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.4 | 6.2 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.4 | 1.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 2.7 | GO:0031105 | septin complex(GO:0031105) |
0.4 | 14.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 4.8 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.4 | 3.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 5.2 | GO:0005901 | caveola(GO:0005901) |
0.4 | 4.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.4 | 10.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 1.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.4 | 31.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.4 | 4.1 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.4 | 20.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 2.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 20.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 2.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.4 | 4.4 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 2.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.4 | 5.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.4 | 2.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 3.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 10.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.4 | 4.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 5.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 8.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 2.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.4 | 1.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.4 | 11.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.4 | 1.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.4 | 4.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 3.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 5.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 2.1 | GO:0034464 | BBSome(GO:0034464) |
0.4 | 2.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.4 | 1.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.7 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 16.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 4.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.3 | GO:0044447 | axoneme part(GO:0044447) |
0.3 | 9.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 73.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 0.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 27.3 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 7.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 7.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 3.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.3 | 0.9 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 0.9 | GO:0032009 | early phagosome(GO:0032009) |
0.3 | 2.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.3 | 11.7 | GO:0000786 | nucleosome(GO:0000786) |
0.3 | 16.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.3 | 1.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.3 | 2.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 12.4 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.3 | 1.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 4.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.2 | 1.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.2 | 2.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 9.6 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 3.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 4.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 4.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.3 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.1 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.4 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 12.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 11.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 21.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 9.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 0.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.3 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 1.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 31.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 0.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.2 | 2.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 2.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 7.7 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 16.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 9.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 0.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 5.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 16.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.2 | 8.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 0.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.0 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 1.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 5.6 | GO:0098793 | presynapse(GO:0098793) |
0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 2.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 15.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 3.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.5 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 2.7 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.9 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 2.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 2.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.3 | GO:0000806 | Y chromosome(GO:0000806) cyclin A2-CDK2 complex(GO:0097124) |
0.1 | 9.3 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 9.4 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.3 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.1 | 1.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 0.1 | GO:0031082 | BLOC complex(GO:0031082) |
0.1 | 64.0 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.1 | 0.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 3.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.8 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 2.4 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 3.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0000322 | storage vacuole(GO:0000322) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 97.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
9.0 | 27.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
7.5 | 7.5 | GO:0070325 | low-density lipoprotein particle receptor binding(GO:0050750) lipoprotein particle receptor binding(GO:0070325) |
6.4 | 19.3 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
5.6 | 5.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
5.1 | 15.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
5.0 | 30.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.8 | 62.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
4.8 | 4.8 | GO:0001851 | complement component C3b binding(GO:0001851) |
4.4 | 13.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
4.3 | 17.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
4.3 | 17.0 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
4.2 | 17.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
4.2 | 12.6 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
3.7 | 14.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
3.5 | 13.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.4 | 48.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
3.4 | 10.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
3.4 | 13.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
3.3 | 13.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
3.3 | 9.9 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
3.3 | 13.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.2 | 9.6 | GO:0032090 | Pyrin domain binding(GO:0032090) |
3.2 | 9.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
3.2 | 9.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
3.1 | 3.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
3.1 | 12.5 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
3.1 | 18.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
3.1 | 15.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
3.1 | 36.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
3.0 | 167.1 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
3.0 | 6.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
3.0 | 18.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
3.0 | 12.0 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
2.9 | 8.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.8 | 11.4 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
2.8 | 14.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
2.8 | 17.0 | GO:0003796 | lysozyme activity(GO:0003796) |
2.8 | 14.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
2.7 | 10.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.7 | 13.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
2.7 | 8.1 | GO:0032093 | SAM domain binding(GO:0032093) |
2.7 | 10.6 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
2.6 | 21.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
2.6 | 7.8 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
2.6 | 7.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
2.6 | 12.8 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
2.5 | 10.1 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
2.5 | 7.5 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
2.5 | 7.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.4 | 7.3 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
2.4 | 26.0 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
2.4 | 14.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
2.4 | 14.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.4 | 23.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.3 | 6.9 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
2.3 | 9.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
2.3 | 6.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.2 | 9.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.2 | 2.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
2.2 | 6.5 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
2.2 | 15.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.2 | 8.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.2 | 8.6 | GO:0017040 | ceramidase activity(GO:0017040) |
2.1 | 6.4 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
2.1 | 14.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
2.1 | 4.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
2.1 | 10.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
2.0 | 8.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
2.0 | 2.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
2.0 | 7.9 | GO:0035473 | lipase binding(GO:0035473) |
2.0 | 2.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
2.0 | 5.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.0 | 11.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
2.0 | 7.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
1.9 | 7.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.9 | 5.8 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
1.9 | 5.7 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
1.9 | 5.6 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
1.9 | 13.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.8 | 5.5 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
1.8 | 3.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.8 | 1.8 | GO:1901375 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
1.8 | 1.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.8 | 10.7 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
1.8 | 1.8 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
1.8 | 8.8 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
1.8 | 10.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.8 | 5.3 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
1.8 | 14.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.8 | 24.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.7 | 5.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
1.7 | 5.2 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
1.7 | 10.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.7 | 8.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.7 | 13.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.7 | 5.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.7 | 1.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.7 | 6.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.7 | 11.6 | GO:0043426 | MRF binding(GO:0043426) |
1.6 | 6.6 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.6 | 16.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.6 | 22.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.6 | 6.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
1.6 | 27.3 | GO:0048156 | tau protein binding(GO:0048156) |
1.6 | 27.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.6 | 19.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.6 | 4.7 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.6 | 28.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.6 | 4.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
1.6 | 6.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.6 | 4.7 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
1.6 | 7.8 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
1.6 | 11.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.6 | 4.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.6 | 3.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
1.5 | 4.6 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.5 | 4.6 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
1.5 | 4.6 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
1.5 | 4.6 | GO:0042806 | fucose binding(GO:0042806) |
1.5 | 10.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.5 | 6.0 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
1.5 | 252.0 | GO:0003823 | antigen binding(GO:0003823) |
1.5 | 26.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.5 | 4.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
1.5 | 4.4 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
1.5 | 4.4 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.5 | 23.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.5 | 8.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.4 | 4.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.4 | 5.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.4 | 4.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.4 | 4.3 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
1.4 | 7.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.4 | 14.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.4 | 4.2 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
1.4 | 4.2 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
1.4 | 6.9 | GO:0004359 | glutaminase activity(GO:0004359) |
1.4 | 31.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.4 | 13.7 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.4 | 2.7 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.4 | 5.5 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
1.3 | 2.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.3 | 4.0 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.3 | 5.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.3 | 16.1 | GO:0034452 | dynactin binding(GO:0034452) |
1.3 | 4.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.3 | 6.7 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
1.3 | 4.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.3 | 9.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.3 | 5.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.3 | 3.9 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
1.3 | 1.3 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
1.3 | 3.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.3 | 5.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.3 | 3.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.3 | 17.7 | GO:0019864 | IgG binding(GO:0019864) |
1.3 | 11.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.3 | 8.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.2 | 5.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.2 | 16.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.2 | 12.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.2 | 8.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.2 | 6.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.2 | 16.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.2 | 20.1 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
1.2 | 3.5 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.2 | 7.0 | GO:0045569 | TRAIL binding(GO:0045569) |
1.2 | 4.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.2 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.2 | 4.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.2 | 13.9 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.2 | 1.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.1 | 6.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.1 | 8.0 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
1.1 | 4.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.1 | 6.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
1.1 | 6.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.1 | 3.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
1.1 | 9.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 4.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.1 | 3.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
1.1 | 3.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.1 | 6.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.1 | 3.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.1 | 5.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.1 | 2.2 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
1.1 | 4.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.1 | 32.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
1.1 | 3.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.1 | 12.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
1.0 | 3.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.0 | 32.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.0 | 7.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.0 | 16.6 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 11.4 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.0 | 13.4 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
1.0 | 9.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 5.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.0 | 4.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.0 | 3.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.0 | 3.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.0 | 5.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 7.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.0 | 10.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.0 | 2.0 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.0 | 4.0 | GO:0035939 | microsatellite binding(GO:0035939) |
1.0 | 3.0 | GO:0034584 | piRNA binding(GO:0034584) |
1.0 | 26.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.0 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.0 | 1.0 | GO:0043559 | insulin binding(GO:0043559) |
1.0 | 3.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
1.0 | 8.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
1.0 | 4.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.0 | 4.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.0 | 4.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.0 | 3.9 | GO:0008940 | nitrate reductase activity(GO:0008940) |
1.0 | 2.9 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.0 | 6.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.0 | 2.9 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
1.0 | 11.5 | GO:0045159 | myosin II binding(GO:0045159) |
1.0 | 2.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.9 | 3.8 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.9 | 8.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.9 | 3.7 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.9 | 4.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.9 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 3.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.9 | 3.6 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.9 | 40.9 | GO:0030507 | spectrin binding(GO:0030507) |
0.9 | 1.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.9 | 13.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.9 | 2.7 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.9 | 15.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.9 | 8.8 | GO:0030274 | LIM domain binding(GO:0030274) |
0.9 | 2.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.9 | 9.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 5.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.9 | 5.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.9 | 6.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.9 | 1.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.9 | 42.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.9 | 2.6 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.9 | 2.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 5.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.9 | 8.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.9 | 4.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.9 | 3.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.9 | 4.3 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.9 | 6.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.9 | 2.6 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.8 | 2.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.8 | 20.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 8.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 5.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.8 | 2.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 5.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.8 | 1.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.8 | 2.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.8 | 4.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.8 | 11.0 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.8 | 45.1 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.8 | 2.3 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.8 | 3.9 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.8 | 0.8 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.8 | 38.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 5.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.8 | 2.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.8 | 13.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.8 | 3.1 | GO:0009975 | cyclase activity(GO:0009975) |
0.8 | 3.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.8 | 3.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.8 | 1.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.8 | 4.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.7 | 9.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 3.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.7 | 3.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.7 | 3.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.7 | 5.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.7 | 1.5 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.7 | 2.9 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.7 | 3.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.7 | 2.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.7 | 71.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.7 | 14.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 2.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.7 | 7.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.7 | 7.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 2.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.7 | 12.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 3.6 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 5.7 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.7 | 2.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.7 | 4.9 | GO:0034979 | NAD-dependent histone deacetylase activity(GO:0017136) NAD-dependent protein deacetylase activity(GO:0034979) |
0.7 | 4.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 8.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.7 | 2.1 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.7 | 2.8 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.7 | 2.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 2.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 4.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.7 | 13.0 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.7 | 5.4 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 2.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.7 | 2.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.7 | 6.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 6.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.7 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.7 | 2.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.6 | 3.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.6 | 3.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.6 | 4.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.6 | 3.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.6 | 4.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.6 | 1.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 6.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.6 | 9.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.6 | 2.5 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.6 | 9.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.6 | 2.5 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.6 | 11.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 9.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.6 | 1.9 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.6 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 3.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 6.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.6 | 2.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.6 | 8.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 4.8 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.6 | 3.0 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.6 | 7.2 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 1.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 10.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.6 | 1.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 10.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.6 | 17.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.6 | 2.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 1.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.6 | 2.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.6 | 3.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.6 | 5.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.6 | 1.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.6 | 14.5 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 2.9 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.6 | 30.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 28.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 5.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.6 | 5.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 8.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 1.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.6 | 5.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.6 | 5.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 10.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 2.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.5 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.5 | 2.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.5 | 7.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 5.4 | GO:1990380 | Lys63-specific deubiquitinase activity(GO:0061578) Lys48-specific deubiquitinase activity(GO:1990380) |
0.5 | 57.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 8.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.5 | 11.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.5 | 4.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 3.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.5 | 6.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 2.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.5 | 1.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.5 | 9.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 3.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 6.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 5.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 7.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.5 | 2.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 3.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.5 | 2.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.5 | 12.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 4.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.5 | 16.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.5 | 2.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.5 | 7.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.5 | 3.0 | GO:0052658 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.5 | 2.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 4.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 1.5 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.5 | 10.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.5 | 3.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.5 | 16.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.5 | 8.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.5 | 11.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 1.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.5 | 1.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.5 | 5.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 2.3 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.5 | 3.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.5 | 1.9 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.5 | 2.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.5 | 3.7 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.5 | 9.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 1.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.4 | 1.8 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 4.5 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.4 | 4.9 | GO:0008430 | selenium binding(GO:0008430) |
0.4 | 2.2 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.4 | 1.3 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 3.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 1.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.4 | 5.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 3.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 3.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.4 | 45.9 | GO:0005179 | hormone activity(GO:0005179) |
0.4 | 2.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.4 | 0.9 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.4 | 4.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 3.4 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 1.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.4 | 8.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.4 | 1.7 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.4 | 19.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.4 | 12.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.4 | 2.9 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 7.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 4.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 18.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.4 | 1.6 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.4 | 2.0 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 1.6 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.4 | 8.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.4 | 3.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 3.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 1.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 10.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.4 | 4.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 6.8 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 2.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.4 | 1.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 8.3 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 4.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 2.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 1.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.4 | 1.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.4 | 3.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.4 | 1.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
0.4 | 40.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 1.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.4 | 1.9 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 52.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.5 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.4 | 2.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.4 | 18.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 1.5 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.4 | 3.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 81.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 1.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.4 | 3.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.4 | 1.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 5.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 2.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.4 | 1.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.4 | 5.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 7.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 1.8 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 4.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 12.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.3 | 4.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 3.8 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 5.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.3 | 3.0 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.3 | 1.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 1.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.0 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.3 | 2.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 9.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 1.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.9 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.3 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 1.8 | GO:0039552 | RIG-I binding(GO:0039552) |
0.3 | 4.7 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.3 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 0.9 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 1.2 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.3 | 1.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.3 | 1.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 8.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 2.9 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 3.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.3 | 10.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 1.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 3.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.3 | 7.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.7 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.3 | 4.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.3 | 5.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 2.8 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 3.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 1.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.4 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 7.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.3 | 1.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.3 | 0.8 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 3.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.3 | 6.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.3 | 4.6 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 6.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 3.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 3.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 0.8 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.3 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 2.0 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 1.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 2.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 2.6 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.7 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 8.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 3.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.5 | GO:0015440 | peptide antigen-transporting ATPase activity(GO:0015433) peptide-transporting ATPase activity(GO:0015440) |
0.2 | 2.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 4.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 2.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 5.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 1.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 3.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.4 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 1.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.2 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 2.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 4.5 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 1.0 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.2 | 2.9 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.2 | 2.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 2.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 0.8 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 2.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 1.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 2.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 11.6 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.2 | 2.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 7.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.2 | 3.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 3.1 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.1 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 4.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 6.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.2 | 0.9 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.2 | 9.2 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 12.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 3.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 0.9 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.2 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 3.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.2 | 0.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 1.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 201.2 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 1.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 6.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.2 | 0.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.2 | 0.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 9.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 32.4 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 3.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 2.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 4.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.5 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.1 | 0.5 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 5.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.1 | 0.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 3.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 2.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 10.5 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 1.6 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 2.7 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 1.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 19.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 0.5 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 7.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 3.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 1.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 4.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 0.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 0.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 1.1 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.6 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 3.2 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.3 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.2 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 1.3 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.0 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
0.0 | 0.0 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 2.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
2.2 | 8.7 | PID INSULIN PATHWAY | Insulin Pathway |
1.8 | 41.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.4 | 58.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.3 | 5.4 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.1 | 13.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 13.9 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
1.0 | 55.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.0 | 10.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.0 | 9.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.9 | 37.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.9 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.9 | 10.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 9.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.8 | 21.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.8 | 47.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.8 | 2.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.7 | 11.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.7 | 4.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 4.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.7 | 21.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 6.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.7 | 26.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.7 | 7.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.7 | 22.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.6 | 1.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 6.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 19.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.6 | 36.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.6 | 29.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 7.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 1.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 79.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.5 | 1.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 17.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.5 | 5.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 10.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 3.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 22.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.5 | 12.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 1.5 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 10.9 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 23.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.5 | 3.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 11.5 | ST ADRENERGIC | Adrenergic Pathway |
0.5 | 2.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.4 | 73.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 14.5 | PID ENDOTHELIN PATHWAY | Endothelins |
0.4 | 2.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.4 | 8.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 20.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.4 | 8.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 94.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 11.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 5.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 1.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 6.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 2.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.3 | 129.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 19.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 15.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 10.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 8.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 18.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.3 | 6.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 5.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 6.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.3 | 16.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 2.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 2.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 3.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 11.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 2.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 1.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 1.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.3 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.5 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 1.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 4.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
2.5 | 44.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.4 | 2.4 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
2.2 | 24.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.8 | 3.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
1.6 | 9.6 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
1.5 | 15.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.5 | 1.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
1.5 | 7.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.4 | 4.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.4 | 20.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.3 | 27.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.3 | 121.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.2 | 17.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.2 | 49.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.2 | 34.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.2 | 25.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.2 | 25.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.2 | 1.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
1.1 | 10.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.1 | 10.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 28.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.0 | 44.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.0 | 3.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.0 | 13.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.0 | 10.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.9 | 16.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.9 | 16.8 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.9 | 10.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.9 | 13.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.9 | 55.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.9 | 27.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.9 | 4.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 17.3 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.8 | 10.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.8 | 17.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.8 | 22.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.8 | 16.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.8 | 4.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.8 | 28.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.8 | 3.8 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.7 | 7.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 10.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.7 | 5.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 16.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.7 | 37.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 4.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 4.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.7 | 3.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.6 | 9.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 1.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 37.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.6 | 28.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 11.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 78.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 4.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 4.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.6 | 10.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.5 | 17.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 6.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 4.3 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.5 | 5.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 4.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.5 | 17.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 8.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.5 | 38.7 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 3.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 12.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.5 | 16.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 38.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 17.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 9.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 1.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.5 | 6.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 9.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 21.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 19.9 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 5.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.4 | 9.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 5.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 7.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 8.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.4 | 8.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.4 | 12.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.4 | 5.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.4 | 7.5 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.4 | 27.0 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 7.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 7.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 10.1 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 2.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 5.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 1.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 5.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 105.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.3 | 4.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.3 | 3.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 4.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.3 | 5.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 33.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 0.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 11.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 3.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 7.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 2.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 12.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 6.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 2.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 2.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 1.8 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.2 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.2 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 16.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 2.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 3.9 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 4.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.6 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 5.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 3.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 4.6 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 4.7 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.1 | 0.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 0.5 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 2.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.1 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 1.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |